“…Morbidity and mortality data could be extracted for 131 of the 150 patients included in this study. Nine deaths (9/131) resulted from disease progression, treatment failure, or metastasis, and no death occurred from LITT treatment [ 11 , 25 ]; 103 patients had no procedural complications and showed stabilization of disease at the time of last follow-up, which ranged from 2 to 24 months [ 11 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 23 , 25 ]; and 19 patients developed intra- or postoperative complications, including transient and permanent neurologic deficits [ 11 , 12 , 14 , 21 , 23 , 25 ]. Procedure-related complications, usually including new neurologic deficits, occurred in approximately 14.5% (19/131) of the pooled sample.…”